0505: Bioresorbable vascular scaffold: preliminary experience of 200 patients and follow up at 18 months of the first 100 - 12/02/16
pages | 2 |
Iconographies | 0 |
Vidéos | 0 |
Autres | 0 |
Résumé |
Background |
Between February 2013 and May 2015, of 2,700 coronary angioplasty procedures realized in our institution, 200 patients aged 65.6 (23-94) underwent coronary stenting with Absorb Biovascular Scaffold.
Clinical data |
exercise angina in 30% of the patients, acute coronary syndroms in 61%, silent ischaemia in 7% and heart failure in 2%.
Procedural data |
all stents have been implanted under angiographic control, only 2 beeing imaged by IVUS, in de novo lesions, through a radial approach with 6 French guiding catheters, following mandatory predilatation. 67% of patents had single vessel desease, 33% multivessel desease. Left anterior descending artery was the target vessel in 64%, the left circumflex in 19% and the right coronary artery in 26%. 212 stents have neen sdelivered with only one failure. 25 patients underwent metallic stenting of other arteries. Side branch angioplasty had to be performed in 4 cases.
In hospital follow up |
No death. One complication withe non Q wave myocardial infraction secondary to side branch occlusion (diagonal branch). One transient ischaemic attack.
Out hospital follow up |
at 22 months (12-27) no stent thrombosis occured. One patient died of cranial traumatism; two patients (1%) had restenosis at the margin of the BVS requiring repeated angioplasty.
Conclusion |
at nearly two years follow up, our data confirm the safety of the device and the low rate of reintervention.
Le texte complet de cet article est disponible en PDF.Plan
Vol 8 - N° 1
P. 10-11 - janvier 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?